Stay updated on Emricasan in NASH Fibrosis Clinical Trial
Sign up to get notified when there's something new on the Emricasan in NASH Fibrosis Clinical Trial page.

Latest updates to the Emricasan in NASH Fibrosis Clinical Trial page
- CheckyesterdayChange DetectedFooter update: Revision v3.4.2 added and Revision v3.4.1 removed; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check8 days agoChange DetectedThe page shows a minor system revision update (Revision: v3.4.1) with no changes to study content, eligibility criteria, outcomes, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedUI/text changes include showing/hiding glossary, capitalization tweaks to QC-related labels, and a new Revision: v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check29 days agoChange DetectedThe page shows a minor revision update from v3.3.3 to v3.3.4 with no obvious changes to core content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check58 days agoChange DetectedThe study's Locations section was updated to reflect new and reorganized site listings across the United States and Germany (including North Rhine-Westphalia). This change is accompanied by a page revision note: v3.3.3.SummaryDifference2%

- Check79 days agoChange DetectedThe additions include a note that publications are automatically filled from PubMed and a new revision label (v3.3.2), while the older PubMed wording was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Emricasan in NASH Fibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Emricasan in NASH Fibrosis Clinical Trial page.